Atlas Trials

A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Infants With Spinal Muscular Atrophy

Clinical trial NCT02193074 · TERMINATED

Trial details

NCT number
NCT02193074
Sponsor
Biogen
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Spinal Muscular Atrophy
Start date
2014-08-19
Primary completion
2016-11-21
Enrollment
122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.